463 related articles for article (PubMed ID: 29671861)
21. Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane.
Rabani V; Montange D; Meneveau N; Davani S
Platelets; 2018 Nov; 29(7):709-715. PubMed ID: 29020490
[TBL] [Abstract][Full Text] [Related]
22. Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
Hobl EL; Derhaschnig U; Firbas C; Schoergenhofer C; Schwameis M; Jilma B
Eur J Clin Invest; 2013 Dec; 43(12):1258-61. PubMed ID: 24112116
[TBL] [Abstract][Full Text] [Related]
23. Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y
Chyrchel B; Drożdż A; Długosz D; Stępień EŁ; Surdacki A
Int J Med Sci; 2019; 16(2):264-275. PubMed ID: 30745807
[No Abstract] [Full Text] [Related]
24. Role of P2Y Receptors in Platelet Extracellular Vesicle Release.
Gąsecka A; Rogula S; Eyileten C; Postuła M; Jaguszewski MJ; Kochman J; Mazurek T; Nieuwland R; Filipiak KJ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842470
[TBL] [Abstract][Full Text] [Related]
25. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
[TBL] [Abstract][Full Text] [Related]
26. Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes.
Wadowski PP; Weikert C; Pultar J; Lee S; Eichelberger B; Koppensteiner R; Lang IM; Panzer S; Gremmel T
Cardiovasc Drugs Ther; 2020 Feb; 34(1):53-63. PubMed ID: 32062795
[TBL] [Abstract][Full Text] [Related]
27. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
[TBL] [Abstract][Full Text] [Related]
28. Epinephrine restores platelet functions inhibited by ticagrelor: A mechanistic approach.
Martin AC; Zlotnik D; Bonete GP; Baron E; Decouture B; Belleville-Rolland T; Le Bonniec B; Poirault-Chassac S; Alessi MC; Gaussem P; Godier A; Bachelot-Loza C
Eur J Pharmacol; 2020 Jan; 866():172798. PubMed ID: 31738933
[TBL] [Abstract][Full Text] [Related]
29. In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y
Rollini F; Franchi F; Thano E; Faz G; Park Y; Kureti M; Cho JR; Been L; Bass TA; Angiolillo DJ
JACC Cardiovasc Interv; 2017 Jul; 10(13):1374-1375. PubMed ID: 28683943
[No Abstract] [Full Text] [Related]
30. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
31. Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
Lei Y; Zhang B; Liu D; Zhao J; Dai X; Gao J; Mao Q; Feng Y; Zhao J; Lin F; Duan Y; Zhang Y; Bao Z; Yang Y; Mou Y; Wang S
J Med Chem; 2020 Dec; 63(24):15752-15772. PubMed ID: 33307675
[TBL] [Abstract][Full Text] [Related]
32. Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.
Connor DE; Ly K; Aslam A; Boland J; Low J; Jarvis S; Muller DW; Joseph JE
Platelets; 2016 Dec; 27(8):805-811. PubMed ID: 27310292
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind Investigation.
Cho JR; Rollini F; Franchi F; DeGroat C; Bhatti M; Dunn EC; Ferrante E; Muniz-Lozano A; Suryadevara S; Zenni MM; Guzman LA; Bass TA; Angiolillo DJ
JACC Cardiovasc Interv; 2015 Jul; 8(8):1075-1083. PubMed ID: 26117466
[TBL] [Abstract][Full Text] [Related]
34. P2Y12 platelet receptors: importance in percutaneous coronary intervention.
Falcão FJ; Carvalho L; Chan M; Alves CM; Carvalho AC; Caixeta AM
Arq Bras Cardiol; 2013 Sep; 101(3):277-82. PubMed ID: 23917456
[TBL] [Abstract][Full Text] [Related]
35. Ticagrelor inverse agonist activity at the P2Y
Khalil J; Dimofte T; Roberts T; Keith M; Amaradasa K; Hindle MS; Bancroft S; Hutchinson JL; Naseem K; Johnson T; Mundell SJ
Br J Pharmacol; 2024 Jan; 181(1):21-35. PubMed ID: 37530222
[TBL] [Abstract][Full Text] [Related]
36. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L
PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y
Mitrugno A; Rigg RA; Laschober NB; Ngo ATP; Pang J; Williams CD; Aslan JE; McCarty OJT
Platelets; 2018 Jun; 29(4):383-394. PubMed ID: 28523947
[TBL] [Abstract][Full Text] [Related]
38. Differential proteomic analysis of platelets suggested target-related proteins in rabbit platelets treated with Rhizoma Corydalis.
Li CH; Chen C; Zhang Q; Tan CN; Hu YJ; Li P; Wan JB; Feng G; Xia ZN; Yang FQ
Pharm Biol; 2017 Dec; 55(1):76-87. PubMed ID: 27653279
[TBL] [Abstract][Full Text] [Related]
39. Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.
Kerneis M; Silvain J; Abtan J; Hauguel M; Barthélémy O; Payot L; Brugier D; Galier S; Collet JP; Montalescot G
Arch Cardiovasc Dis; 2015 Oct; 108(10):502-10. PubMed ID: 26113480
[TBL] [Abstract][Full Text] [Related]
40. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
